| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Marpai, Inc. (MRAI) has 10 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. MRAI is classified in the Health Care Providers & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 1.77M | $444.4K | - | |
| CEO | 1.35M | $338.9K | - | |
| Dir | 1.09M | $273.4K | - | |
| CFO | 898.1K | $225.4K | - | |
| Pres | 410.0K | $102.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 16, 2024 | Pons Robert M | Director | Buy | 12,100 | $0.92 | $11,133.21 | +100.0% | |
| Jan 16, 2024 | Lamendola Damien | Chief Executive Officer | Buy | 1,100,000 | $0.92 | $1,012,110.00 | +129.2% | |
| Jan 16, 2024 | Eitan Yaron | Director | Buy | 210,000 | $0.92 | $193,221.00 | +53.6% | |
| Dec 14, 2023 | Eitan Yaron | Director | Buy | 50,000 | $1.97 | $98,500.00 | +14.6% | |
| Dec 14, 2023 | Pons Robert M | Director | Buy | 12,100 | $1.81 | $21,901.00 | New | |
| Dec 14, 2023 | Lamendola Damien | Chief Executive Officer | Buy | 150,000 | $1.97 | $295,500.00 | +21.4% | |
| Nov 21, 2023 | Lamendola Damien | Chief Executive Officer | Buy | 200,000 | $1.19 | $238,680.00 | New | |
| Nov 17, 2023 | Eitan Yaron | Director | Buy | 100,000 | $1.23 | $123,000.00 | +41.4% | |
| Sep 11, 2023 | Gonzalez Edmundo | Chief Executive Officer | Buy | 42,000 | $0.77 | $32,340.00 | +18.9% | |
| Jun 21, 2023 | Gonzalez Edmundo | Chief Executive Officer | Buy | 20,000 | $0.51 | $10,102.00 | +2.3% |